Canada markets closed

Embla Medical hf. (OSSFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
4.50010.0000 (0.00%)
At close: 10:30AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.79B
Enterprise Value 2.28B
Trailing P/E 33.33
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.39
Price/Book (mrq)2.63
Enterprise Value/Revenue 2.83
Enterprise Value/EBITDA 15.76

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-6.25%
S&P500 52-Week Change 322.36%
52 Week High 34.9700
52 Week Low 33.6300
50-Day Moving Average 34.5161
200-Day Moving Average 34.3057

Share Statistics

Avg Vol (3 month) 31.13k
Avg Vol (10 day) 3N/A
Shares Outstanding 5426.93M
Implied Shares Outstanding 6461.48M
Float 8157.81M
% Held by Insiders 10.11%
% Held by Institutions 180.29%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 13, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 7.08%
Operating Margin (ttm)7.60%

Management Effectiveness

Return on Assets (ttm)3.82%
Return on Equity (ttm)8.25%

Income Statement

Revenue (ttm)804.32M
Revenue Per Share (ttm)1.88
Quarterly Revenue Growth (yoy)10.30%
Gross Profit (ttm)N/A
EBITDA 107.8M
Net Income Avi to Common (ttm)56.93M
Diluted EPS (ttm)0.1400
Quarterly Earnings Growth (yoy)-15.00%

Balance Sheet

Total Cash (mrq)77.36M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)559.76M
Total Debt/Equity (mrq)76.22%
Current Ratio (mrq)1.68
Book Value Per Share (mrq)1.71

Cash Flow Statement

Operating Cash Flow (ttm)92.83M
Levered Free Cash Flow (ttm)29.46M